Stocks
JNJ Shares Hold High Despite Lowered Earnings Forecast
Johnson & Johnson (NYSE:JNJ) shares closed at their highest level since July 29, despite a 5.5% decrease in its adjusted earnings forecast for 2026.
The company's stock price rose 0.9% to $259.24 on Friday, with analysts' sentiment improving as FactSet reports 19 Buy or Overweight ratings, up from 17 three months ago.
The lowered profit forecast was due to the buyout of Firefly Bio and collaboration with Sail Biomedicines, which trimmed the midpoint by $0.64, representing a 5.5% decrease compared to the previous outlook.
Despite this adjustment, J&J's valuation remains high, with its price reflecting 23.5 times the updated midpoint, indicating investors see these costs as investments in the pipeline rather than signs of declining operations.